Decoding 5 Analyst Evaluations For Maravai LifeSciences
Decoding 5 Analyst Evaluations For Maravai LifeSciences
解讀5位分析師對maravai lifesciences的評估
Analysts' ratings for Maravai LifeSciences (NASDAQ:MRVI) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 2 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.2, a high estimate of $15.00, and a low estimate of $7.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.27%.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of Maravai LifeSciences's perception among financial experts is painted...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間